Citadel Advisors’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.4M Buy
665,044
+194,164
+41% +$3.62M ﹤0.01% 1237
2025
Q1
$8.54M Buy
470,880
+48,842
+12% +$886K ﹤0.01% 1356
2024
Q4
$9.2M Buy
422,038
+362,737
+612% +$7.91M ﹤0.01% 1377
2024
Q3
$1.62M Buy
+59,301
New +$1.62M ﹤0.01% 2684
2024
Q2
Sell
-24,829
Closed -$745K 6086
2024
Q1
$745K Buy
+24,829
New +$745K ﹤0.01% 3489
2023
Q4
Sell
-105,561
Closed -$1.44M 6039
2023
Q3
$1.44M Sell
105,561
-104,439
-50% -$1.43M ﹤0.01% 2689
2023
Q2
$2.55M Buy
210,000
+209,449
+38,013% +$2.54M ﹤0.01% 2236
2023
Q1
$7.01K Buy
551
+62
+13% +$789 ﹤0.01% 5575
2022
Q4
$3.09K Sell
489
-2,027
-81% -$12.8K ﹤0.01% 5845
2022
Q3
$56K Buy
+2,516
New +$56K ﹤0.01% 5279
2022
Q2
Sell
-8,750
Closed -$406K 6182
2022
Q1
$406K Buy
+8,750
New +$406K ﹤0.01% 4644
2021
Q4
Hold
0
6579
2021
Q3
Sell
-8,642
Closed -$1.35M 6500
2021
Q2
$1.35M Sell
8,642
-39,821
-82% -$6.23M ﹤0.01% 3646
2021
Q1
$9.18M Buy
48,463
+42,174
+671% +$7.99M ﹤0.01% 1505
2020
Q4
$789K Buy
6,289
+1,634
+35% +$205K ﹤0.01% 3483
2020
Q3
$506K Sell
4,655
-755
-14% -$82.1K ﹤0.01% 3486
2020
Q2
$650K Sell
5,410
-1,421
-21% -$171K ﹤0.01% 3235
2020
Q1
$686K Buy
6,831
+1,340
+24% +$135K ﹤0.01% 3159
2019
Q4
$1.33M Sell
5,491
-5,791
-51% -$1.4M ﹤0.01% 2727
2019
Q3
$1.85M Sell
11,282
-3,035
-21% -$498K ﹤0.01% 2427
2019
Q2
$3.38M Buy
14,317
+3,428
+31% +$809K ﹤0.01% 1975
2019
Q1
$2.87M Buy
10,889
+9,546
+711% +$2.52M ﹤0.01% 2010
2018
Q4
$122K Buy
+1,343
New +$122K ﹤0.01% 3969
2018
Q3
Sell
-5,425
Closed -$1.17M 4369
2018
Q2
$1.17M Buy
+5,425
New +$1.17M ﹤0.01% 2528